A Marcus Gunn pupil, also known as a relative afferent pupillary defect (RAPD), is a clinical sign detected on the swinging flashlight test indicating asymmetric damage to the afferent visual pathway — most commonly the optic nerve. It is not a disease itself but a critical physical exam finding that points to serious underlying pathology requiring urgent evaluation. [1-3]
1. History
- Onset and tempo of vision loss: Acute (seconds → retinal artery occlusion), subacute over hours-to-days (→ optic neuritis), progressive over weeks-to-months (→ compressive lesion, glaucoma) [1-2]
- Unilateral vs. bilateral: RAPD indicates asymmetric disease; unilateral vision loss localizes to the eye or prechiasmal pathway [1]
- Pain: Retro-orbital pain worsening with eye movement is highly suggestive of optic neuritis. Painless loss suggests ischemic or compressive etiology [1-2]
- Flashes/floaters/curtain defect: Suggests retinal detachment [1]
- Transient monocular vision loss (amaurosis fugax): Prior episodes suggest retinal artery occlusion or carotid disease [1]
- Temporal headache, jaw claudication, scalp tenderness: Suggests giant cell arteritis (GCA) [1]
- History of high myopia, prior eye surgery, trauma: Risk factors for retinal detachment and traumatic optic neuropathy [1]
- MS history or prior episodes of optic neuritis: Recurrent demyelinating disease [4]
2. Alarm Features
- Sudden painless profound vision loss → central retinal artery occlusion (stroke equivalent, time-sensitive) [1]
- Age >50 with headache, jaw claudication, scalp tenderness → GCA; risk of bilateral blindness, aortic dissection, stroke if untreated [1]
- RAPD in the setting of trauma → traumatic optic neuropathy; poor prognostic sign for visual recovery [3]
- Progressive vision loss with proptosis → compressive optic neuropathy (tumor, orbital mass) [5-6]
- Bilateral or severe optic neuritis, focal neurologic signs → NMOSD, MOGAD, or other aggressive autoimmune optic neuropathy [1][4]
- New RAPD with altered consciousness or focal neuro deficits → intracranial mass with midbrain compression [7]
3. Medications
- Relevant contributors: Ethambutol, methanol, linezolid, and other toxic/metabolic optic neuropathy agents
- Treatments by etiology:
- Optic neuritis: IV methylprednisolone 1 g/day × 3 days, then oral prednisone 1 mg/kg/day × 11 days with taper. Inappropriately low oral steroid dosing increases recurrence risk [1]
- GCA: Empiric IV methylprednisolone 15 mg/kg/day × 3 days → oral prednisone ≥1 mg/kg/day. Do NOT delay for biopsy [1]
- Acute angle-closure glaucoma (if concurrent): Topical timolol, pilocarpine, systemic acetazolamide or IV mannitol [1]
- Contraindicated: Low-dose oral prednisone alone for optic neuritis (associated with increased recurrence) [1]
4. Diet
- Not directly applicable to the acute finding
- In toxic/nutritional optic neuropathies: assess for B12 deficiency, folate deficiency, heavy alcohol use, and tobacco-alcohol amblyopia
- Adequate hydration and nutrition counseling for patients on prolonged corticosteroid therapy
5. Review of Systems
- Neurologic: Focal weakness, numbness, gait disturbance, prior demyelinating episodes (MS) [4]
- Rheumatologic/Systemic: Jaw claudication, scalp tenderness, polymyalgia rheumatica symptoms, weight loss, fever, night sweats (GCA) [1]
- Vascular: History of TIA, stroke, cardiovascular risk factors (hypertension, diabetes, dyslipidemia, smoking) [1]
- Ophthalmologic: Floaters, flashes, curtain defect, color desaturation, eye pain with movement [1]
- Constitutional: Fatigue, weight loss, fever (GCA, malignancy, sarcoidosis)
6. Collateral History and Family History
- Witnesses to onset timing (critical for retinal artery occlusion — 4.5-hour thrombolysis window) [1]
- Family history of MS, autoimmune disease, glaucoma, hereditary optic neuropathies (e.g., Leber hereditary optic neuropathy) [1]
- Social history: Alcohol, tobacco, nutritional status, occupational exposures (methanol, solvents)
- Medication reconciliation for toxic optic neuropathy agents
7. Risk Factors
- Optic neuritis: Young women (median age 31), 3:1 female predominance, MS history [1]
- Ischemic optic neuropathy (NAION): Age >50, hypertension, diabetes, hyperlipidemia, small crowded optic disc ("disc at risk"), obstructive sleep apnea [2]
- GCA: Age >50, female sex (6:1), Northern European descent, polymyalgia rheumatica [1]
- Retinal artery occlusion: Cardiovascular risk factors, atrial fibrillation, carotid stenosis [1]
- Retinal detachment: High myopia (≥−6.0 diopters), prior cataract surgery, trauma, diabetes [1]
- Compressive optic neuropathy: Neurofibromatosis type 1 (optic glioma), intracranial tumors [6]
- Traumatic optic neuropathy: Head/facial trauma [3]
8. Differential Diagnosis
The RAPD localizes the lesion to the afferent visual pathway. Causes can be organized anatomically: [2][7]
- Optic nerve (most common site):
- Optic neuritis (MS, MOGAD, NMOSD)
- Ischemic optic neuropathy (arteritic/GCA vs. non-arteritic)
- Compressive optic neuropathy (meningioma, glioma, pituitary adenoma)
- Traumatic optic neuropathy
- Toxic/nutritional optic neuropathy (ethambutol, methanol, B12 deficiency)
- Glaucoma (advanced, asymmetric)
- Retina:
- Central retinal artery occlusion [1][8]
- Extensive retinal detachment [1]
- Large asymmetric retinal disease (e.g., severe CRVO)
- Optic chiasm: Asymmetric chiasmal compression (pituitary tumor)
- Postchiasmal (rare): Contralateral optic tract lesion or dorsal midbrain lesion — RAPD without visual field loss is possible with pretectal lesions [7][9]
Cannot-miss diagnoses: GCA (bilateral blindness risk), central retinal artery occlusion (stroke equivalent), compressive lesion (tumor), traumatic optic neuropathy
9. Past Medical History
- Prior episodes of optic neuritis or MS diagnosis
- Cardiovascular disease, hypertension, diabetes, dyslipidemia, atrial fibrillation
- Glaucoma history (asymmetric disease can produce RAPD)
- Prior eye surgeries, trauma, high myopia
- Autoimmune conditions (sarcoidosis, lupus, vasculitis)
- Cancer history (metastatic compression, paraneoplastic)
10. Physical Exam
Swinging Flashlight Test (the defining test): [1][5][10]
- Performed in a dimly lit room with the patient fixating on a distant target
- Shine a bright light into one eye for <5 seconds, then swing quickly to the other eye
- Normal: Both pupils constrict or maintain size when light swings
- Abnormal (RAPD positive): The affected pupil dilates when the light swings to it, indicating reduced afferent input from that eye
Additional key exam components
- Visual acuity each eye separately (with pinhole correction) [1]
- Color vision/red desaturation (red cap test) — washed-out red in the affected eye suggests optic neuropathy [1]
- Confrontation visual fields — altitudinal defect (AION), central scotoma (optic neuritis), peripheral curtain (retinal detachment) [1-2]
- Funduscopy: Disc edema (AION, papillitis), pallor (chronic optic neuropathy), cherry red spot (CRAO), retinal whitening, hemorrhages [1-2]
- Extraocular movements: Pain with eye movement (optic neuritis), restriction (orbital mass)
- Temporal artery palpation: Tender, pulseless, firm artery (GCA) [1]
Pearl: An RAPD is NOT expected in amblyopia (a large RAPD in a patient with "lazy eye" should prompt search for compressive or other pathology). [5] In trauma, the presence of an RAPD is a poor prognostic sign for visual recovery. [3]
11. Lab Studies
Labs are guided by the suspected etiology:
- GCA workup (age >50 with vision loss): ESR, CRP, CBC with platelets — elevated ESR, CRP, and thrombocytosis support the diagnosis [1]
- Retinal artery occlusion / stroke workup: Fasting glucose, HbA1c, lipid panel, CBC, PT/PTT [1]
- Optic neuritis with red flags: AQP4-IgG (NMOSD), MOG-IgG (MOGAD), ANA, ACE level (sarcoidosis), RPR/FTA-ABS (syphilis), Lyme serologies [4]
- Toxic/nutritional: B12, folate, methylmalonic acid, methanol level if suspected
- Monitoring: Glucose and bone density for patients on prolonged steroids
12. Imaging
- MRI brain and orbits with contrast (first-line for suspected optic neuropathy): Identifies optic nerve enhancement (optic neuritis), compressive lesions, demyelinating plaques [4][6]
- Short-segment unilateral enhancement → MS-associated optic neuritis
- Long-segment or bilateral enhancement → MOGAD or NMOSD
- Optic nerve sheath/perioptic enhancement → MOGAD [6]
- CT/CTA head: If retinal artery occlusion suspected — emergent stroke protocol; also carotid imaging [1]
- B-scan ocular ultrasound: Useful for retinal detachment when fundus view is obscured [1]
- Temporal artery ultrasound: "Halo sign" in GCA [1]
- CT orbits: Trauma setting — orbital fractures, retrobulbar hemorrhage
- Imaging is unnecessary for isolated, typical optic neuritis in a young patient with classic presentation (though MRI brain is recommended to assess MS risk) [1]
13. Special Tests
- Swinging flashlight test: The bedside test that defines the RAPD [1][5]
- Red cap test: Quick screen for color desaturation — patient compares redness of an object between eyes [1]
- Optical coherence tomography (OCT): Quantifies retinal nerve fiber layer thinning (chronic optic neuropathy) and ganglion cell loss [2]
- Visual evoked potentials (VEP): Can confirm optic neuropathy when diagnosis is unclear or detect subclinical disease [2]
- Automated perimetry (Humphrey visual fields): Characterizes visual field defect pattern
- Ultrasound pupillometry: Objective RAPD quantification; AUC = 1.0 for detecting acute optic neuritis vs. controls [11]
- Fluorescein angiography: Retinal vascular occlusions
- Temporal artery biopsy: Gold standard for GCA confirmation (do not delay steroids) [1]
14. ECG
- Indicated when retinal artery occlusion is identified — part of the stroke/embolic workup [1]
- Assess for atrial fibrillation, ischemic changes, or other arrhythmias as embolic sources
- Echocardiography should also be considered for valvular or cardiac source of emboli [1]
- Not routinely indicated for optic neuritis or other non-vascular causes of RAPD
15. Assessment
A Marcus Gunn pupil (RAPD) is a sign, not a diagnosis. It indicates asymmetric damage to the afferent visual pathway and is always pathologic when clearly present. [2] The clinical significance depends entirely on the underlying etiology:
- Optic neuritis (young patients): Generally good visual prognosis; 50% develop MS [1][4]
- NAION: Typically stable after initial insult; no proven treatment [2]
- GCA: Medical emergency — untreated, risk of contralateral blindness within days [1]
- CRAO: Stroke equivalent — time-sensitive evaluation for thrombolysis [1]
- Traumatic optic neuropathy: RAPD is a poor prognostic sign for recovery [3]
- Compressive lesions: Progressive unless treated surgically
A subtle RAPD may be seen with dense amblyopia, but a large, easily visible RAPD is NOT typical of amblyopia and should prompt further investigation. [5]
16. Treatment Plan
Treatment is entirely etiology-dependent
- Optic neuritis: IV methylprednisolone 1 g/day × 3 days (or oral bioequivalent prednisone 1,250 mg/day × 3 days), then oral prednisone 1 mg/kg/day × 11 days with 3-day taper [1]
- GCA: Empiric IV methylprednisolone 15 mg/kg/day × 3 days → oral prednisone ≥1 mg/kg/day. Do not delay for biopsy [1]
- CRAO: Emergent stroke protocol — consider IV thrombolysis within 4.5 hours; consult stroke neurology. Address modifiable cardiovascular risk factors [1]
- Retinal detachment: Urgent ophthalmology referral for surgical repair (vitrectomy, scleral buckle, pneumatic retinopexy) [1]
- Compressive optic neuropathy: Neurosurgical consultation for decompression/resection [6]
- Traumatic optic neuropathy: Controversial — high-dose steroids vs. observation vs. surgical decompression
- NAION: No proven acute treatment; optimize cardiovascular risk factors [2]
17. Disposition
- Admit:
- GCA with vision loss (empiric steroids, temporal artery biopsy) [1]
- CRAO within thrombolysis window (stroke protocol) [1]
- Traumatic optic neuropathy with concurrent head injury
- Suspected intracranial compressive lesion
- Urgent ophthalmology referral (same day):
- Retinal detachment [1]
- CRAO outside thrombolysis window
- Severe optic neuritis
- Outpatient with close follow-up:
- Typical optic neuritis in a young patient after steroid initiation (with MRI brain to assess MS risk) [1]
- Stable NAION with risk factor optimization
- Specialist consultation triggers: Ophthalmology for all new RAPD findings; neurology for suspected MS/NMOSD/MOGAD; neurosurgery for compressive lesions; vascular surgery for carotid disease
18. Follow Up / Return Precautions
- Optic neuritis: Follow-up with ophthalmology and neurology within 1–2 weeks; MRI brain for MS risk stratification. Return for worsening vision, new neurologic symptoms, or contralateral eye involvement [1]
- GCA: Close rheumatology/ophthalmology follow-up for steroid taper over 1–2 years; return immediately for vision changes in the other eye [1]
- CRAO: Cardiology/vascular follow-up for secondary stroke prevention; high risk of cerebrovascular or myocardial infarction [1]
- Return precautions for all patients:
- Any new or worsening vision loss
- Vision loss in the contralateral eye
- New headache, focal weakness, numbness, or speech difficulty
- Eye pain, flashes, floaters, or curtain defect
- Expected course: Varies by etiology — optic neuritis typically improves over weeks (though contrast sensitivity may remain impaired); NAION and CRAO often have permanent deficits [1-2]
References
1. Sudden Vision Loss: A Diagnostic Approach. — Fraser JA, Son M, Vinokurtseva A. American Family Physician. 2025.
2. Diagnosis and Clinical Features of Common Optic Neuropathies. — Biousse V, Newman NJ. The Lancet. Neurology. 2016.
3. Eye Injuries. — Shingleton BJ. The New England Journal of Medicine. 1991.
4. Optic Neuritis and Autoimmune Optic Neuropathies: Advances in Diagnosis and Treatment. — Bennett JL, Costello F, Chen JJ, et al. The Lancet. Neurology. 2023.
5. Pediatric Eye Evaluations Preferred Practice Pattern. — Hutchinson AK, Morse CL, Hercinovic A, et al. Ophthalmology. 2023.
6. ACR Appropriateness Criteria® Vision Loss. — Expert Panel on Neurological Imaging, Friedman ER, Juliano AF, et al. Journal of the American College of Radiology : JACR. 2025.
7. Isolated Relative Afferent Pupillary Defect Secondary to Contralateral Midbrain Compression. — Chen CJ, Scheufele M, Sheth M, et al. Archives of Neurology. 2004.
8. Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern®. — Kovach JL, Bailey ST, Kim SJ, et al. Ophthalmology. 2025.
9. Pupillographic Investigation of the Relative Afferent Pupillary Defect Associated With a Midbrain Lesion. — Kawasaki A, Miller NR, Kardon R. Ophthalmology. 2010.
10. Evaluation of the Visual System by the Primary Care Provider Following Concussion. — Master CL, Bacal D, Grady MF, et al. Pediatrics. 2022.
11. Ultrasound Pupillometry for the Detection of a Relative Afferent Pupillary Defect (RAPD): Systematic Evaluation in Patients With Optic Neuritis and Comparison With Infrared Video Pupillometry. — Siebald F, Grittner U, Otto C, et al. PloS One. 2024.